← Insider buys
RETA

Reata Pharmaceuticals Inc

Chief Development Officer Keith Wayne Ward sold $3.7M of Reata Pharmaceuticals Inc

Sold$3,678,585
$91.13Price
40,367Shares
−82%Stake

What RETA did after the filing

Prices for RETA after this filing aren't in yet.

Traded Mon, Feb 25. Filed Wed, Feb 27, 11:22 AM ET, during the session. Not investment advice.